International consensus statement on quality standards for managing children/adolescents with bronchiectasis from the ERS CRC Child-BEAR-Net
- PMID: 35680151
- DOI: 10.1183/13993003.00264-2022
International consensus statement on quality standards for managing children/adolescents with bronchiectasis from the ERS CRC Child-BEAR-Net
Conflict of interest statement
Conflict of interest: E. Alexopoulou, A. Bush, A.J. Collaro, C. Constant, K. Douros, R. Fortescue, M. Griese, K. Grimwood, A. Hector, A.T. Hill, A. Kantar, B. Karadag, O. Mazulov, F. Midulla, A. Moeller, Z. Powell, M. Proesmans, C. Wilson, S.T. Yerkovich and A. Zacharasiewicz have nothing to disclose. A.B. Chang reports grants from the National Health and Medical Research Council, Australia, during the conduct of the study; is an IDMC member for an unlicensed vaccine (GSK) and an unlicensed monoclonal antibody (AstraZeneca); is an advisory member of study design for an unlicensed molecule for chronic cough (Merck); and reports personal fees from being an author of two UpToDate chapters, all outside the submitted work. J. Boyd is an employee of the European Lung Foundation. J.D. Chalmers reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Insmed, personal fees from Chiesi, Novartis and Zambon, and grants from Gilead Sciences, outside the submitted work. J. Grigg reports grants and personal fees from OM Pharma, and personal fees from GSK, Novartis, Omron and AstraZeneca, outside the submitted work.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources